COR.NYSECencora, INC

Form 4: Cencora CEO Sells Shares After Option Exercise

Sentiment:

Insider Transaction Report


Cencora's President & CEO, Robert P. Mauch, reported the exercise of stock options and subsequent sale of common stock on December 18, 2025.

Summary

  • Robert P. Mauch, President & CEO and Director of Cencora, Inc. (COR), reported transactions on December 18, 2025.
  • Mauch acquired 3,763 shares of Common Stock at an exercise price of $86.09 per share through the exercise of non-qualified stock options.
  • Following the acquisition, Mauch disposed of 5,096 shares of Common Stock at a price of $343.45 per share.
  • These transactions were made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
  • After these transactions, Mauch beneficially owns 68,059 shares of Common Stock directly.
  • Mauch also holds 7,525 non-qualified stock options, which are exercisable in four equal installments from November 13, 2020, to November 13, 2023, and expire on November 13, 2026.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction involving the exercise of stock options and subsequent sale of shares, executed under a Rule 10b5-1 plan. While an insider sale can sometimes be viewed negatively, the context of an option exercise and pre-planned disposition makes it a neutral event for market sentiment.

Positives

  • The exercise of stock options indicates a prior grant of equity compensation, aligning management interests with shareholders.
  • The sale price of $343.45 per share is significantly higher than the exercise price of $86.09 per share, indicating a substantial gain for the insider.

Negatives

  • An insider sale, even if pre-planned under a Rule 10b5-1 plan, can sometimes be perceived negatively by the market, potentially suggesting a lack of further upside potential from the insider's perspective.
  • There was a net reduction in direct beneficial ownership of common stock by 1,333 shares (5,096 shares sold minus 3,763 shares acquired).

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

  • Shareholders: May interpret the sale as a signal, but the 10b5-1 plan mitigates negative perception. The net reduction in direct ownership is minor relative to total shares outstanding.

Key Dates

DateDescription
11/13/2020First installment exercisable date for non-qualified stock option.
11/13/2021Second installment exercisable date for non-qualified stock option.
11/13/2022Third installment exercisable date for non-qualified stock option.
11/13/2023Fourth installment exercisable date for non-qualified stock option.
12/18/2025Date of earliest transaction (stock option exercise and common stock sale).
12/22/2025Signature date of reporting person's attorney-in-fact.
11/13/2026Expiration date for non-qualified stock option.

Recommendation

hold

The Form 4 details a pre-planned insider transaction involving the exercise of stock options and subsequent sale of shares by Cencora's President & CEO. Such transactions, especially when executed under a Rule 10b5-1 plan, are generally considered routine for liquidity or diversification purposes and do not typically signal a change in the company's fundamental outlook. Therefore, a 'hold' recommendation is appropriate as this filing does not provide new information to alter an existing investment thesis.

Keywords

Cencora, COR, Insider Trading, Form 4, Stock Option Exercise, Share Sale, Robert P. Mauch, CEO, Director, 10b5-1 Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.